» Articles » PMID: 31190950

Evaluation of Discriminative Capacity of Two Formulas of CKD-EPI to Predict Complications After the First Episode of Heart Failure with Preserved Ejection Fraction

Overview
Publisher Dove Medical Press
Specialty Nephrology
Date 2019 Jun 14
PMID 31190950
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Determining the prognosis of heart failure with preserved ejection fraction (HFpEF) is problematic, as the ejection fraction cannot be used. Formulae that estimate glomerular filtration rate (eGFR) may be potential prognosticators for this condition, since renal dysfunction is a well-known predictor of poor outcomes of all forms of heart failure. A prospective observational study of 117 HFpEF patients (average age 71.6±9.1 years; 65.8% women) who had eGFR determined after their first episode of cardiac decompensation by two different chronic kidney disease epidemiology collaboration (CKD-EPI) equations. The ability to predict hospitalizations and mortality over 24 months by the two equations were compared. The CKD-EPI formula based on serum creatinine only performed poorly. However, the CKD-EPI equation that used both serum creatinine and serum cystatin C was associated with unfavorable outcome: eGFR <45 mL/min/1.73 m predicted 24-month mortality (HR=4.21 [1.32;13.43], =0.02) and the combined endpoint of mortality and hospitalization (HR 2.45 [1.42;4.22], =0.001). . eGFR by the CKD-EPI equation based on serum creatinine and cystatin C levels, but not by the CKD-EPI creatinine only equation, predicts the outcome of HFpEF patients.

Citing Articles

Nonindexed versus Body Surface Area-Indexed Measured GFR Determinations as a Criterion of Living Donor Acceptance.

Matar A, Helgeson E, Seegmiller J, Ramanathan K, Finger E, Kandaswamy R Clin J Am Soc Nephrol. 2025; 20(3):432-439.

PMID: 39819788 PMC: 11905994. DOI: 10.2215/CJN.0000000606.


Estimation of glomerular filtration rate in cardiorenal patients: a step forward.

Quiroga B, Diez J Clin Kidney J. 2023; 16(7):1049-1055.

PMID: 37398687 PMC: 10310511. DOI: 10.1093/ckj/sfad083.


B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction.

Ghilencea L, Bejan G, Zamfirescu M, Stanescu A, Matei L, Manea L J Pers Med. 2022; 12(6).

PMID: 35743676 PMC: 9225135. DOI: 10.3390/jpm12060890.


The Prognostic Impact of Estimated Creatinine Clearance by Bioelectrical Impedance Analysis in Heart Failure: Comparison of Different eGFR Formulas.

Scicchitano P, Iacoviello M, Passantino A, Guida P, De Palo M, Piscopo A Biomedicines. 2021; 9(10).

PMID: 34680423 PMC: 8533548. DOI: 10.3390/biomedicines9101307.


Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?.

Shah K, Fang J Curr Hypertens Rep. 2019; 21(11):86.

PMID: 31599363 DOI: 10.1007/s11906-019-0993-0.

References
1.
Smith G, Lichtman J, Bracken M, Shlipak M, Phillips C, DiCapua P . Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006; 47(10):1987-96. DOI: 10.1016/j.jacc.2005.11.084. View

2.
Bhatia R, Tu J, Lee D, Austin P, Fang J, Haouzi A . Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355(3):260-9. DOI: 10.1056/NEJMoa051530. View

3.
Madero M, Sarnak M, Stevens L . Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens. 2006; 15(6):610-6. DOI: 10.1097/01.mnh.0000247505.71915.05. View

4.
Lassus J, Harjola V, Sund R, Siirila-Waris K, Melin J, Peuhkurinen K . Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J. 2007; 28(15):1841-7. DOI: 10.1093/eurheartj/ehl507. View

5.
Naruse H, Ishii J, Kawai T, Hattori K, Ishikawa M, Okumura M . Cystatin C in acute heart failure without advanced renal impairment. Am J Med. 2009; 122(6):566-73. DOI: 10.1016/j.amjmed.2008.10.042. View